The market sentiment is picking up, and Calliditas is interesting ahead of the critical PDUFA date (20 December). Does the recent patent notice matter? Yes, typically, it is a green light for issuing the patent within six weeks, and we can expect Calliditas to continue to find ways to improve the patent situation once the US Orphan drug exclusivity expires seven years after the initial approval in late 2021.
LÄS MER